LncRNA UCA1 regulates immune micro-environment in cisplatin-induced AKI by miRNA-4498/AKT3 pathway
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0314654 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Peng Hongjun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nanjing Drum Tower Hospital, Affiliated hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Cisplatin, RNA, Long Noncoding, MicroRNAs, Acute Kidney Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
An increasing number of studies highlight the significance of long non-coding RNAs (lncRNAs) in the biological process of acute kidney injury (AKI). This study investigates the role and the mechanism of lncRNA UCA1 in cisplatin-induced AKI. Real-time quantitative PCR was used to measure lncRNA UCA1 expression in cisplatin-induced AKI mouse model, showing that lncRNA UCA1 was overexpressed. Knockdown of lncRNA UCA1 by shRNA significantly reduced inflammation caused by cisplatin treatment. A co-culture system demonstrated that lncRNA UCA1 upregulation in T cells induced apoptosis of tubular epithelial cells (TECs). A dual-luciferase reporter assay confirmed that lncRNA UCA1 acts as a miR-4498 sponge, binding to the 3’UTR of AKT3. Flow cytometry and ELISA results showed that reduced inflammation effect induced by lncRNA UCA1 knockdown was reversed by miR-4498 inhibition or AKT3 overexpression. Our findings suggest that lncRNA UCA1 functions as a miR-4498 sponge, upregulating AKT3 expression, and promoting inflammation in cisplatin-induced AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Nanjing Drum Tower Hospital, Affiliated hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
- Jiangsu Key Laboratory for Biodiversity and Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, Jiangsu, China.
- Department of Pediatrics, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
ORCID-Profile: Lydia Mukanhaire, Ren Xianguo
Zitieren
APA
Hongjun, P., Mukanhaire, L., Zhen, L., Ting, W., Hongye, L., Xiaotian, Z., Guangling, L., & Xianguo, R. (2025). LncRNA UCA1 regulates immune micro-environment in cisplatin-induced AKI by miRNA-4498/AKT3 pathway. PLOS ONE. https://doi.org/10.1371/journal.pone.0314654
Vancouver
Hongjun P, Mukanhaire L, Zhen L, Ting W, Hongye L, Xiaotian Z, et al. LncRNA UCA1 regulates immune micro-environment in cisplatin-induced AKI by miRNA-4498/AKT3 pathway. PLOS ONE. 2025. doi:10.1371/journal.pone.0314654
BibTeX
@article{Hongjun2025,
author = {Hongjun, Peng and Mukanhaire, Lydia and Zhen, Liu and Ting, Wang and Hongye, Li and Xiaotian, Zhang and Guangling, Liu and Xianguo, Ren},
title = {LncRNA UCA1 regulates immune micro-environment in cisplatin-induced AKI by miRNA-4498/AKT3 pathway},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0314654}
}
EUVIMED